Advertisement

Topics

Seattle Genetics halts trials of latest ADC after safety warning

06:41 EDT 21 Jun 2017 | pharmaphorum

Seattle Genetics has halted all trials of its vadastuximab talirine after a review uncovered a high death rate in acute myeloid leukaemia patients treated with the drug. The antibody-drug conjugate (ADC) specialist said it took the action after co...

Original Article: Seattle Genetics halts trials of latest ADC after safety warning

NEXT ARTICLE

More From BioPortfolio on "Seattle Genetics halts trials of latest ADC after safety warning"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...